Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
boston top stories
deals
life sciences
national blog main
startups
3
×
clinical trials
drug delivery
fda
investing
medical device
new york blog main
san francisco blog main
vc
480 biomedical
arrowmark partners
arsenal medical
azacitidine
beta bionics
beta-thalassemia
bigfoot biomedical
bob langer
boston university
chronic rhinosinusitis
congenital hyperinsulinism
covid-19
dacogen
decitabine
dexcom
diabetes
dna
edward damiano
eli lilly
epigenetics
epizyme
eventide asset management
farydak
flagship pioneering
What
developing
3
×
biotech
million
new
startup
tests
therapeutics
aims
approach
based
beta
bionics
blood
called
closed
company
debut
debuts
device
diabetes
driven
drugs
epigenetic
epigenetics
field
flagship’s
heads
ipo
key
late
levels
lyra
manages
markets
medical
medicines
monitors
morning
nose
noses
Language
unset
Current search:
startups
×
boston
×
developing
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests